IRIS
LEONARDI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.762
AS - Asia 3.920
EU - Europa 2.955
SA - Sud America 695
Continente sconosciuto - Info sul continente non disponibili 244
AF - Africa 230
OC - Oceania 7
Totale 14.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.566
SG - Singapore 1.092
CN - Cina 1.028
IE - Irlanda 791
HK - Hong Kong 647
BR - Brasile 519
RU - Federazione Russa 463
VN - Vietnam 417
DE - Germania 382
IT - Italia 382
FR - Francia 209
FI - Finlandia 194
BD - Bangladesh 156
IN - India 145
ZA - Sudafrica 142
GB - Regno Unito 119
CA - Canada 96
NL - Olanda 83
AT - Austria 70
AR - Argentina 57
MX - Messico 57
IQ - Iraq 55
JP - Giappone 55
TR - Turchia 44
PL - Polonia 39
SE - Svezia 39
ID - Indonesia 35
UA - Ucraina 35
ES - Italia 34
PH - Filippine 34
CO - Colombia 29
PK - Pakistan 29
SA - Arabia Saudita 23
AE - Emirati Arabi Uniti 22
EC - Ecuador 22
VE - Venezuela 22
MA - Marocco 21
UZ - Uzbekistan 20
BE - Belgio 18
MY - Malesia 17
JO - Giordania 15
CL - Cile 14
PE - Perù 12
CZ - Repubblica Ceca 11
LT - Lituania 11
TH - Thailandia 10
CR - Costa Rica 9
ET - Etiopia 9
JM - Giamaica 9
KE - Kenya 9
KZ - Kazakistan 9
MK - Macedonia 9
NP - Nepal 9
RO - Romania 9
TN - Tunisia 9
PA - Panama 8
UY - Uruguay 8
AL - Albania 7
CH - Svizzera 7
DZ - Algeria 7
IL - Israele 7
PT - Portogallo 7
AZ - Azerbaigian 6
KG - Kirghizistan 6
PY - Paraguay 6
RS - Serbia 6
SN - Senegal 6
AU - Australia 5
EG - Egitto 5
LB - Libano 5
MU - Mauritius 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
GE - Georgia 4
GT - Guatemala 4
AO - Angola 3
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
KW - Kuwait 3
PS - Palestinian Territory 3
UG - Uganda 3
BH - Bahrain 2
CM - Camerun 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NO - Norvegia 2
PR - Porto Rico 2
QA - Qatar 2
SR - Suriname 2
SY - Repubblica araba siriana 2
Totale 14.545
Salva come PNG Salva come JPEG
Città #
San Jose 941
Dublin 790
Ashburn 706
Hong Kong 635
Chandler 552
Singapore 514
Dallas 476
Council Bluffs 305
Beijing 280
New York 206
Los Angeles 194
Lauterbourg 173
Boardman 164
Ho Chi Minh City 151
Princeton 144
Munich 140
Lawrence 138
Medford 137
Helsinki 131
Johannesburg 129
Hanoi 113
Wilmington 112
Redondo Beach 74
Moscow 72
Santa Clara 72
Nuremberg 69
Buffalo 59
Pavia 59
Milan 58
Shanghai 58
Orem 49
Tokyo 48
Turku 48
Jacksonville 44
São Paulo 44
Chicago 43
Washington 41
Nanjing 39
Warsaw 38
Atlanta 36
Falkenstein 35
Montreal 35
Vienna 33
Rio de Janeiro 32
Columbus 31
Chennai 30
Brooklyn 29
Norwalk 28
Toronto 27
Changsha 25
Haiphong 24
London 24
Amsterdam 23
Phoenix 23
Seattle 23
Hangzhou 22
The Dalles 21
Baghdad 20
Frankfurt am Main 20
Da Nang 19
San Francisco 19
Ankara 18
Fairfield 18
Mexico City 18
New Delhi 17
Rome 17
Tashkent 17
Woodbridge 17
Brussels 16
Denver 16
Hebei 16
Belo Horizonte 15
Poplar 15
Tomsk 15
Amman 14
Guangzhou 14
Houston 14
Redwood City 14
Stockholm 14
Ann Arbor 13
Dhaka 12
Nanchang 12
Quito 12
Boston 11
Curitiba 11
Karachi 11
Manchester 11
Riyadh 11
Hyderabad 10
Mumbai 10
Paris 10
Porto Alegre 10
Tianjin 10
Buenos Aires 9
Caracas 9
Düsseldorf 9
Jakarta 9
Nairobi 9
Wuhan 9
Bologna 8
Totale 9.126
Salva come PNG Salva come JPEG
Nome #
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 435
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC) 358
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis 211
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment 181
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 150
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 147
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 146
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 136
Alirocumab and cardiovascular outcomes after acute coronary syndrome 136
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention 133
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 129
Sotagliflozin in patients with diabetes and recent worsening heart failure 129
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 128
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes 127
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 125
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 124
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 122
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 122
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 121
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 120
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group 119
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 117
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 117
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 117
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease). 115
Rivaroxaban with or without aspirin in stable cardiovascular disease 114
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 114
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 114
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 113
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 112
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 111
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 107
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 107
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 106
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention 105
Utilità della risonanza magnetica cardiaca nella valutazione del profilo emodinamico di pazienti con ipertensione polmonare post-embolica: uno studio di confronto con il cateterismo cardiaco destro. 103
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 103
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 103
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study 100
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial 99
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 99
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 98
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial 96
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 96
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 95
Role of cardiac magnetic resonance in the avaluation of the hemodynamic profile of patients with severe chronic thromboembolic pulmonary hypertension: a comparison with right heart catheterization 94
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 94
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 93
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 92
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 92
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 92
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes 91
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 90
Usefulness of cardiac megnetic resonance in assessing reverse right ventricular remodeling in patients with chronic thromboembolic pulmonary hypertension after pulmonary endarteriectomy 90
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 90
Incidence of ventricular arrhythmias and 1-year predictors of mortality in patients treated with implantable cardioverter-defibrillator undergoing generator replacement 90
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 89
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial 88
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease 88
The prognostic value of serial troponin measurements in patients admitted for COVID-19 88
Acute Cardiovascular Care 2019 87
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? 87
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 86
Clinical governance of patients with acute coronary syndromes 85
Apixaban versus warfarin in patients with atrial fibrillation 85
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 85
Parenteral antithrombotic therapy during primary percutaneous coronary intervention 84
Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes 84
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY 84
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 83
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 83
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 83
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 82
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial 82
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y 12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: The INNOVATE-PCI trial 82
Association of Troponin Levels with Mortality in Italian Patients Hospitalized with Coronavirus Disease 2019: Results of a Multicenter Study 81
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY 81
A novel approach to systematically implement the universal definition of myocardial infarction: Insights from the CHAMPION PLATFORM trial 78
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome 78
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 76
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 76
Composition, structure, and function of heart teams: A joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization 75
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 74
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study 73
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasivemanagement: Secondary analysis of a randomized clinical trial 72
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study 72
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function 72
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score 72
Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX) 71
Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study 69
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data 69
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS 69
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed 68
Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era 68
[GISE (Italian Society of Interventional Cardiology) Position paper: Short-term hospitalization for percutaneous coronary intervention; a helpful tool to manage post-COVID-19 backlogs] 67
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 66
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting 66
Around the clock, around the world-reflections on 24 hours of acute cardiovascular care 66
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 65
[Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives] 65
Totale 10.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022580 0 33 9 8 10 5 12 35 27 9 88 344
2022/20231.813 233 140 18 91 121 145 3 93 894 15 39 21
2023/2024823 60 170 39 39 74 239 9 64 2 45 31 51
2024/20252.824 80 165 29 55 74 218 225 158 732 143 304 641
2025/20267.148 614 433 753 657 867 230 1.426 382 593 562 373 258
2026/2027995 396 599 0 0 0 0 0 0 0 0 0 0
Totale 14.813